DrugPatentWatch Database Preview
Details for Patent: 8,158,616
» See Plans and Pricing
Which drugs does patent 8,158,616 protect, and when does it expire?
Patent 8,158,616 protects OLUMIANT and is included in one NDA.
This patent has fifty-four patent family members in forty-two countries.
Summary for Patent: 8,158,616
| Title: | Azetidine and cyclobutane derivatives as JAK inhibitors |
| Abstract: | The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer. |
| Inventor(s): | Rodgers; James D. (Landenberg, PA), Shepard; Stacey (Voorhees, NJ) |
| Assignee: | Incyte Corporation (Wilmington, DE) |
| Application Number: | 12/401,348 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,158,616
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | OLUMIANT | baricitinib | TABLET;ORAL | 207924-001 | May 31, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,158,616
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009223640 | Start Trial | |||
| Brazil | PI0909040 | Start Trial | |||
| Canada | 2718271 | Start Trial | |||
| Chile | 2009000576 | Start Trial | |||
| China | 102026999 | Start Trial | |||
| China | 103788098 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
